New shot could ease stuffy noses and polyps for sinusitis sufferers

NCT ID NCT07519577

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study tests a biologic drug called CM512 in 120 people with chronic sinusitis and nasal polyps. Participants receive the drug as a shot under the skin. The goal is to see if it is safe and helps control symptoms. All participants have been in a previous CM512 study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CM512 (a biologic drug given as a shot under the skin)

What this could lead to

If it works, this could point toward a new treatment option to control symptoms and reduce nasal polyps in people with chronic sinusitis.

What could go wrong

This is an early phase 2 study with no placebo group, so results may not prove effectiveness. Side effects are possible, and the drug may not work for everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Tong-Ren hospital

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••